BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Unicycive Therapeutics, Inc. (UNCY)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Unicycive Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
4:29 pm
Purchase		 2024-09-30 13G Unicycive Therapeutics, Inc.
UNCY		 BIOTECHNOLOGY VALUE FUND L P 10,471,230
9.990%		 7,001,005increase
(+201.74%)		 Filing
2023-07-06
5:23 pm
Purchase		 2023-06-26 13G Unicycive Therapeutics, Inc.
UNCY		 BIOTECHNOLOGY VALUE FUND L P 3,470,225
9.990%		 3,470,225increase
(New Position)		 Filing